CUE — Cue Biopharma Share News
0.000.00%
Last trade - 00:00- $102.72m
- $86.34m
- $27.47m
U.S. RESEARCH ROUNDUP- Air Products and Chemicals, Armstrong World Industries, Lennar
Cue Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Cue Biopharma Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: Cue Biopharma Reports Two Objective Responses (1 Cpr And 1Upr) In First Interim Update From Dose Escalation Portion Of Ongoing Phase 1 Combination Study Of Cue-101 And Keytruda® In First Line Patients With Hpv+ Recurrent/Metastatic Head And Neck Cancer
Brief: Cue Biopharma To Host Business Update Call And Webcast For Ongoing Cue-101 Clinical Trials
Brief: Cue Biopharma And Lg Chem Life Sciences Announce Development Milestone In Immuno-Stat Biologics Collaboration For Cue-102
Brief: Cue Biopharma Announces Appointment Of Patricia Nasshorn As Chief Business Officer
Brief: Cue Biopharma Presents Updated Data From Lead Program CUE-101 Cancer Treatment At SITC Meeting
Brief: Cue Biopharma Enters Into Open Market Sale Agreement
U.S. STOCKS ON THE MOVE-Helbiz, Big Lots, AutoZone, Stoke Therapeutics
Cue Biopharma rises on new U.S. patents for lead cancer therapy
Brief: Cue Biopharma Inc Posts Qtrly Collaboration Revenue $2.7 Million Versus $1.1 Million
Cue Biopharma Inc reports results for the quarter ended in June - Earnings Summary
Cue Biopharma Inc expected to post a loss of 42 cents a share - Earnings Preview
Cue Biopharma Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Cue Biopharma Announces First Patient Dosed In Part B Patient Expansion Of Cue-101 Phase 1 Monotherapy Trial In Hpv+ Second Line And Beyond Hnscc
Brief: Cue Biopharma Posts Quarterly Loss Per Share Of $0.41
Cue Biopharma Inc reports results for the quarter ended in March - Earnings Summary
Brief: Cue Biopharma Reports Confirmed Partial Response (Pr) In Ongoing Phase 1 Monotherapy Study Of Cue-101 In Late Stage Second Line And Beyond Patients With Hpv+ Recurrent/Metastatic Head And Neck Cancer